• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Tingling (2171)
Event Type  Injury  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the calcium that was provided to the patient.Since this event is associated with the treatment, this mdr will be against the instrument.From the instrument perspective, there was no known instrument malfunction and no instrument issue was alleged by the customer.No service was requested by the customer for this adverse event.No product was returned; therefore, a device service history review was performed.The instrument has been located at the customer's site since 28-jun-2014.As part of the review, it was determined that the instrument's last service was on 21-dec-2018.During this service the system checkout procedure was successfully completed indicating that the instrument had passed all tests, met all specifications, and was operational.Based on an assessment of the complaint description, the customer did acknowledge that the tingling that the patient experienced was due to the nurses forgetting to hang the calcium for the patient.The customer stated that tingling was a common reaction when acda is used as an anticoagulant and that calcium is usually given along side the acda in order to counterbalance a possible citrate reaction.The customer reported that when the nurses hung the two grams of calcium the patient's tingling stopped and the patient's treatment was completed without any further issues.The most likely cause for this adverse event was the fact that the nurses did not provide the patient with calcium while acda was being used as the anticoagulant for the patient's treatment procedure.Trends were reviewed for complaint category, tingling.No trends were detected for this complaint category.The assessment is based on information available at the time of the investigation.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: tingling.Mc (b)(4).(b)(6), 03/06/2019.
 
Event Description
The customer reported that an extracorporeal photopheresis (ecp) patient experienced tingling during a treatment procedure.The customer stated that this was their first time treating a patient who had heparin induced thrombocytopenia.The customer reported that due to this affliction they could not use heparin as the anticoagulant for this patient's treatment procedure.The customer stated that they used acda at a 10:1 ratio as the anticoagulant for this patient's treatment procedure.The customer reported that the tingling that was experienced by the patient was due to the acda anticoagulant.The customer stated that tingling is a common reaction when acda is used as an anticoagulant and that calcium is usually given alongside the acda in order to counterbalance a possible citrate reaction.The customer reported that the nurses who were performing this patient's treatment procedure forgot to hang the patient's calcium.The customer stated that when the patient started to complain of tingling, the nurses hung two grams of calcium and the patient's tingling stopped.The customer reported that there were no further issues with the patient's treatment procedure.The customer stated that the patient's treatment procedure was completed as normal with both blood and treated cells returned to the patient.The customer reported that the patient was in stable condition.No product was returned for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS
bedminster NJ
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin D15 T X2V
EI   D15 TX2V
Manufacturer Contact
megan vernak
1425 us route 206
bedminster, NJ 07921
MDR Report Key8397074
MDR Text Key138082439
Report Number2523595-2019-00030
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Nurse
Type of Report Initial
Report Date 03/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCELLEX
Device Lot NumberNOT APPLICABLE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/04/2019
Initial Date FDA Received03/06/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/09/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age54 YR
-
-